Pharmaceuticals & Biotech|Product Engineering

Prima Mente
Early disease detection

Standard DNA tests miss early Alzheimer’s signals. An AI model now detects these invisible chemical markers with 0.89 accuracy.

PublishedFeb 2, 2026|1 week ago

Key results

Pattern Match Rate
91%
Generation Accuracy
83%
Concentration Increase
up to 20x

Result highlights

Unlock 5 result highlights

The story

An AI biology startup based in London and San Francisco aims to cure severe neurological conditions by understanding the brain across health, age, and disease.

Neurological diseases like Alzheimer's develop gradually with subtle symptoms, making early detection difficult when relying solely on traditional...

Unlock full story

Quotes

Unlock 1 more quote

The company

Prima Mente logo

Prima Mente

primamente.com

Biological foundation models for neurological research and brain health.

IndustryPharmaceuticals & Biotech
LocationLondon, United Kingdom
Employees11-50
Founded2023

Implementation partner

Provided Prima Mente with NVIDIA supercomputing clusters and technical support for model training.

IndustryTechnology
LocationAmsterdam, Netherlands
Employees251-1K
Founded2023

119 AI case studies in Pharmaceuticals & Biotech

1,341 AI case studies in Product Engineering